156589-97-8 Usage
Uses
Used in Pharmaceutical Industry:
Cyclobutanecarbothioamide is utilized as a key intermediate in the synthesis of pharmaceuticals for its ability to contribute to the formation of complex molecular structures that can have therapeutic effects.
Used in Agrochemical Industry:
In the agrochemical sector, Cyclobutanecarbothioamide is employed as an intermediate in the production of various agrochemicals, potentially enhancing crop protection and management strategies.
Used in Organic Compound Synthesis:
Cyclobutanecarbothioamide serves as an intermediate in the synthesis of organic compounds, facilitating the creation of a wide range of chemical products with diverse applications.
Safety Note:
It is crucial to handle Cyclobutanecarbothioamide with caution due to its potential to cause irritation to the skin, eyes, and respiratory system upon exposure, emphasizing the need for proper safety measures during its use and manipulation.
Check Digit Verification of cas no
The CAS Registry Mumber 156589-97-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,6,5,8 and 9 respectively; the second part has 2 digits, 9 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 156589-97:
(8*1)+(7*5)+(6*6)+(5*5)+(4*8)+(3*9)+(2*9)+(1*7)=188
188 % 10 = 8
So 156589-97-8 is a valid CAS Registry Number.
InChI:InChI=1/C5H9NS/c6-5(7)4-2-1-3-4/h4H,1-3H2,(H2,6,7)
156589-97-8Relevant academic research and scientific papers
BENZODIAZEPINE DERIVATIVES AS RSV INHIBITORS
-
Page/Page column 71, (2020/10/09)
The present invention discloses compounds of Formula (I), or pharmaceuticall acceptable salts, esters, or prodrugs thereof: which inhibit Respiratory Syncytial Virus (RSV). The present invention further relates to pharmaceutical compositions comprising th
SUBSTITUTED THIAZOLE OR OXAZOLE P2X7 RECEPTOR ANTAGONISTS
-
Page/Page column 39, (2015/09/22)
The present invention refers to novel substituted thiazole and oxazole compounds of formula (I) having P2X7 receptor (P2X7) antagonistic properties. The compounds are useful in the treatment or prophylaxis of diseases associated with P2X7 receptor activity in animals, in particular humans.
CYCLOALKYLTHILAZOLES
-
, (2008/06/13)
Compounds of the formula: STR1 wherein the substituents are as described in the specification, antagonize LTD 4 action and thus, are useful in treating bronchial asthma, pulmonary anaphylaxis, cystic fibrosis, chronic bronchitis, bronchiectasis, respiratory distress syndrome and pulmonary oedema.
